Trial Outcomes & Findings for Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails (NCT NCT00999687)
NCT ID: NCT00999687
Last Updated: 2019-08-07
Results Overview
The nail is divided by imaginary horizontal and longitudinal lines into quadrants. Each nail is given a score for nail bed psoriasis (0-4) and nail matrix psoriasis (0-4) depending on the presence of any of the features of nail psoriasis in that quadrant. The NAPSI score evaluates presence of signs in the nail bed (of onycholysis, splinter hemorrhages, nail bed discoloration, and subungual hyperkeratosis) and on the nail matrix (pitting, leukonychia, red spots in the lunula and nail plate crumbling) in all 10 fingernails, providing a minimal score of 0 and a maximum of 80. This study is an intra-patient side-to-side comparison, it measures nail disease on a single hand. All 5 fingers in each group were scored providing a maximum score of 40 and a minimal of 0. The modified target NAPSI score for the target nail scores severity of nail matrix and nail-bed psoriasis from 0 (no sign) to 3 (severe involvement) in each nail quadrant, providing a maximum score of 96 and a minimal of 0.
COMPLETED
PHASE2/PHASE3
31 participants
Baseline and Week 12
2019-08-07
Participant Flow
Participants recruited from ambulatory department of Chang Gung Memorial Hospital, in northern Taiwan between November 2009 and May 2011.
35 participants recruited and screened, 4 excluded (3 did not meet the eligibility criteria and 1 refused participation).
Participant milestones
| Measure |
All Participants (Indigo Naturalis Oil Extract /Olive Oil)
In all participants, indigo naturalis oil extract (INOE) was applied to the fingernails of one bilateral hand (experimental group) and olive oil was applied to the fingernails of the contralateral hand (control group) twice daily for 12 weeks. The randomization process was conducted by block randomization method with 1:1 ratio. After 12 weeks, olive oil treatment was discontinued and INOE was applied to both hands twice daily for another 12 weeks.
|
|---|---|
|
First Intervention
STARTED
|
31
|
|
First Intervention
COMPLETED
|
30
|
|
First Intervention
NOT COMPLETED
|
1
|
|
Second Intervention
STARTED
|
30
|
|
Second Intervention
COMPLETED
|
27
|
|
Second Intervention
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
All Participants (Indigo Naturalis Oil Extract /Olive Oil)
In all participants, indigo naturalis oil extract (INOE) was applied to the fingernails of one bilateral hand (experimental group) and olive oil was applied to the fingernails of the contralateral hand (control group) twice daily for 12 weeks. The randomization process was conducted by block randomization method with 1:1 ratio. After 12 weeks, olive oil treatment was discontinued and INOE was applied to both hands twice daily for another 12 weeks.
|
|---|---|
|
First Intervention
Withdrawal by Subject
|
1
|
|
Second Intervention
Withdrawal by Subject
|
2
|
|
Second Intervention
Lack of Efficacy
|
1
|
Baseline Characteristics
Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails
Baseline characteristics by cohort
| Measure |
All Participants (Indigo Naturalis Oil Extract /Olive Oil)
n=31 Participants
In all participants, indigo naturalis oil extract was applied to the fingernails of one bilateral hand (experimental group) and olive oil was applied to the fingernails of the contralateral hand (control group) twice daily for 12 weeks. The randomization process was conducted by block randomization method with 1:1 ratio. After 12 weeks, olive oil treatment was discontinued and indigo naturalis oil extract was applied to both hands twice daily for another 12 weeks.
|
|---|---|
|
Age, Continuous
|
40.7 years
STANDARD_DEVIATION 12.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
24 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline and Week 12Population: Higher values represent a worse outcome. For example, a higher score at baseline and a lower score after treatment represent an improvement.
The nail is divided by imaginary horizontal and longitudinal lines into quadrants. Each nail is given a score for nail bed psoriasis (0-4) and nail matrix psoriasis (0-4) depending on the presence of any of the features of nail psoriasis in that quadrant. The NAPSI score evaluates presence of signs in the nail bed (of onycholysis, splinter hemorrhages, nail bed discoloration, and subungual hyperkeratosis) and on the nail matrix (pitting, leukonychia, red spots in the lunula and nail plate crumbling) in all 10 fingernails, providing a minimal score of 0 and a maximum of 80. This study is an intra-patient side-to-side comparison, it measures nail disease on a single hand. All 5 fingers in each group were scored providing a maximum score of 40 and a minimal of 0. The modified target NAPSI score for the target nail scores severity of nail matrix and nail-bed psoriasis from 0 (no sign) to 3 (severe involvement) in each nail quadrant, providing a maximum score of 96 and a minimal of 0.
Outcome measures
| Measure |
Experimental Group
n=30 Participants
Using Indigo Naturalis Oil Extract (INOE) from week 0 to week 24.
|
Control Group
n=30 Participants
Using Olive Oil from week 0 to week 12, then change to Indigo Naturalis Oil Extract (INOE) from week 13 to week 24.
|
|---|---|---|
|
Change From Baseline in Single-Hand Nail Psoriasis Severity Index (NAPSI)and in the Modified Target NAPSI for the Single Most Severely Affected Nail of Each Hand at Week 12.
Change from Baseline in Single-Hand NAPSI
|
-10.9 units on a scale
95% Confidence Interval 6.0 • Interval -13.3 to -8.52
|
-4.9 units on a scale
Interval -6.95 to -2.78
|
|
Change From Baseline in Single-Hand Nail Psoriasis Severity Index (NAPSI)and in the Modified Target NAPSI for the Single Most Severely Affected Nail of Each Hand at Week 12.
Change from Baseline in Modified-Target NAPSI
|
-8.1 units on a scale
Interval -9.97 to -6.23
|
-2.2 units on a scale
Interval -3.76 to -0.57
|
PRIMARY outcome
Timeframe: Baseline and Week 24Population: Higher values represent a worse outcome. For example, a higher score at baseline and a lower score after treatment represent an improvement.
The nail is divided by imaginary horizontal and longitudinal lines into quadrants. Each nail is given a score for nail bed psoriasis (0-4) and nail matrix psoriasis (0-4) depending on the presence of any of the features of nail psoriasis in that quadrant. The NAPSI score evaluates presence of signs in the nail bed (of onycholysis, splinter hemorrhages, nail bed discoloration, and subungual hyperkeratosis) and on the nail matrix (pitting, leukonychia, red spots in the lunula and nail plate crumbling) in all 10 fingernails, providing a minimal score of 0 and a maximum of 80. This study is an intra-patient side-to-side comparison, it measures nail disease on a single hand. All 5 fingers in each group were scored providing a maximum score of 40 and a minimal of 0. The modified target NAPSI score for the target nail scores severity of nail matrix and nail-bed psoriasis from 0 (no sign) to 3 (severe involvement) in each nail quadrant, providing a maximum score of 96 and a minimal of 0.
Outcome measures
| Measure |
Experimental Group
n=27 Participants
Using Indigo Naturalis Oil Extract (INOE) from week 0 to week 24.
|
Control Group
n=27 Participants
Using Olive Oil from week 0 to week 12, then change to Indigo Naturalis Oil Extract (INOE) from week 13 to week 24.
|
|---|---|---|
|
Change From Baseline in Single-Hand Nail Psoriasis Severity Index (NAPSI)and in the Modified Target NAPSI for the Single Most Severely Affected Nail of Each Hand at Week 24.
Change from Baseline in Single-Hand NAPSI
|
-13.4 units on a scale
Interval -16.4 to -10.5
|
-11.6 units on a scale
Interval -14.2 to -9.05
|
|
Change From Baseline in Single-Hand Nail Psoriasis Severity Index (NAPSI)and in the Modified Target NAPSI for the Single Most Severely Affected Nail of Each Hand at Week 24.
Change from Baseline in Modified-Target NAPSI
|
-10.6 units on a scale
Interval -12.6 to -8.54
|
-8.0 units on a scale
Interval -9.74 to -6.34
|
Adverse Events
All Participants (Indigo Naturalis Oil Extreact/Olive Oil)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place